Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 9 No. 12, December 2008
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puopolo, K. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Puopolo, K. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

NeoReviews Vol.9 No.12 2008 e571
© 2008 American Academy of Pediatrics

Epidemiology of Neonatal Early-onset Sepsis

Karen M. Puopolo, MD, PhD*

* Assistant Professor of Pediatrics, Harvard Medical School; Attending Physician, Channing Laboratory and Department of Newborn Medicine, Brigham and Women's Hospital and Division of Newborn Medicine, Children's Hospital, Boston

Neonatal early-onset sepsis (EOS) continues to be a significant source of morbidity and mortality among newborns, especially among very-low birthweight infants. Epidemiologic risk factors for EOS have been defined, and considerable resources are devoted to the identification and evaluation of infants at risk for EOS. The widespread implementation of intrapartum antibiotic prophylaxis for the prevention of early-onset neonatal group B Streptococcus (GBS) disease has reduced the overall incidence of neonatal EOS and influenced the microbiology of persistent early-onset infection. Most early-onset neonatal GBS disease now occurs in preterm infants or in term infants born to mothers who have negative GBS screening cultures. Ongoing clinical challenges include reassessment of clinical risk factors for EOS in the era of GBS prophylaxis; more accurate identification of GBS-colonized women; and continued surveillance of the impact of GBS prophylaxis practices on the microbiology of EOS, particularly among very low-birthweight infants.

Abbreviations: BWH: Brigham and Women's Hospital • CDC: Centers for Disease Control and Prevention • EOS: early-onset sepsis • GBS: group B Streptococcus • IAP: intrapartum antibiotic prophylaxis • MRSA: methicillin-resistant Staphylococcus aureus • NICHD: National Institute of Child Health and Development • NICU: neonatal intensive care unit • PCR: polymerase chain reaction • VLBW: very low birthweight


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Academy of Pediatrics.